Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 02 - 23 symbols : Lly save search
Innovent Announces First Patient Dosed with CD73 Antibody in Phase 1a/1b Clinical Trial for Advanced Solid Tumor
Published: 2022-02-23 (Crawled : 01:00) - biospace.com/
LLY | News | $750.77 0.54% 0.22% 2.8M
|
Health Technology
|
| O: 0.59%
H: 0.89%
C: -0.93%
INCY | $52.72 -0.94% -0.91% 2.1M
|
Health Technology
|
| O: 0.87%
H: 0.84%
C: -1.12%
cd73 trial phase 1 antibody phase 1b
Worldwide Drug Delivery Industry to 2027 - Growing Focus Towards Home Care and Self-Administration Presents Opportunities
Published: 2022-02-23 (Crawled : 18:00) - prnewswire.com
GNMSF | $281.02 -1.44% 3.83% 210
|
Health Technology
|
| O: 5.23%
H: 0.0%
C: -0.34%
GLAXF | $20.2 0.65% -14.18% 290
|
Health Technology
|
| O: -0.48%
H: 3.79%
C: 3.12%
AZNCF | $140.15 3.58% -4.19% 560
|
Health Technology
|
| O: 1.68%
H: 0.0%
C: -1.1%
WST | $377.36 -0.56% 0.0% 360K
|
Health Technology
|
| O: 0.24%
H: 0.24%
C: -3.38%
NVS | News | $93.08 -0.13% 0.13% 1.1M
|
Health Technology
|
| O: 1.82%
H: 0.07%
C: -1.0%
MDT | News | $79.08 -0.22% 0.25% 4.6M
|
Health Technology
|
| O: 0.5%
H: 0.25%
C: -1.16%
JNJ | News | $144.77 0.22% 0.22% 7.9M
|
Health Technology
|
| O: 0.23%
H: 0.7%
C: -0.18%
GSK | $39.6 -0.88% 0.03% 2.6M
|
Health Technology
|
| O: 1.9%
H: 0.07%
C: -0.87%
LLY | News | $750.77 0.54% 0.22% 2.8M
|
Health Technology
|
| O: 0.59%
H: 0.89%
C: -0.93%
BDX | $232.21 0.52% -0.04% 1.2M
|
Health Technology
|
| O: 0.22%
H: 1.9%
C: 1.48%
ABBV | $164.25 1.05% 0.26% 3M
|
Health Technology
|
| O: 0.45%
H: 1.46%
C: 0.37%
MMM | $90.96 -0.1% 0.39% 2.9M
|
Producer Manufacturing
|
| O: 0.0%
H: 0.4%
C: -1.61%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: 2.09%
H: 0.08%
C: -1.22%
GMAB | $28.53 -3.06% -3.23% 310K
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: -1.67%
AZN | $68.53 0.39% 0.39% 3.2M
|
Health Technology
|
| O: 1.43%
H: 0.0%
C: -1.85%
ATRS | $5.59 0.0%
|
Health Technology
|
| O: 0.29%
H: 0.87%
C: -2.6%
AMGN | $264.07 -0.59% -0.59% 1.6M
|
Health Technology
|
| O: 0.57%
H: 0.48%
C: -0.75%
drug liver growing drug delivery
With Market Size Valued At $2.8 Billion By 2026, It`s A Healthy Outlook For The Global Cancer Cachexia Market
Published: 2022-02-23 (Crawled : 16:00) - prnewswire.com
AZNCF | $140.15 3.58% -4.19% 560
|
Health Technology
|
| O: 1.68%
H: 0.0%
C: -1.1%
LLY | News | $750.77 0.54% 0.22% 2.8M
|
Health Technology
|
| O: 0.59%
H: 0.89%
C: -0.93%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 1.19%
H: 0.0%
C: -6.18%
AZN | $68.53 0.39% 0.39% 3.2M
|
Health Technology
|
| O: 1.43%
H: 0.0%
C: -1.85%
health cancer
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
INVO | $1.82 139.47% 56.82% 220M
|
Health Technology
SINT | $0.0373 62.88% 37.26% 460M
|
Health Technology
WISA 4 | $9.25 51.64% 34.27% 64M
|
Electronic Technology
EDBL | News | $6.66 46.37% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 600K
|
Manufacturing
TCON | $2.29 33.92% 26.61% 1.8M
|
Health Technology
TIRX | $0.4848 7.49% 24.58% 5.9M
|
SRFM 4 | $0.3859 -12.3% 23.84% 660K
|
n/a
CTM | $0.2201 -2.31% 22.67% 48K
|
n/a
VNDA | News | $5.24 29.38% 22.56% 24M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.